SEATTLE–(BUSINESS WIRE)–Pluristyx, Inc., an advanced therapy tools and services biotechnology company, panCELLa, a privately held biotechnology company, and Implant Therapeutics, a developer of genetically engineered stem cells, today announced they have entered into a manufacturing […]
CAMBRIDGE, Mass.: CAMBRIDGE, Mass., Jan. 20, 2022 /PRNewswire/ — Particles for Humanity has raised $4 million from the Bill & Melinda Gates Foundation, King Philanthropies, and the Mulago Foundation to address vitamin A deficiency in […]
PORTLAND, Ore.: PORTLAND, Ore., Jan. 20, 2022 /PRNewswire/ — Allied Market Research published a report, titled, "Cancer Supportive Care Drugs Market by Type (Erythropoiesis-Stimulating Agents (ESA), Granulocyte Colony-Stimulating Factors (G-CSFs), Antiemetics, Bisphosphonates, Opioids, NSAIDs (Non-Steroidal […]
SEATTLE: SEATTLE, Jan. 19, 2022 /PRNewswire-PRWeb/ — Today, SANESolution (SANE) is announcing the launch of the first POSTBiotic Continuing Education Course accredited by the Commission on Dietetic Registration (Academy of Nutrition and Dietetics). Now available […]
SEATTLE–(BUSINESS WIRE)–Today the Access to Advanced Health Institute (AAHI) announced its upcoming launch and central role in a new global coalition, Africa’s Access to Advanced Healthcare (AAAH). The mission of The AAAH Coalition is to […]
SEATTLE and LONDON: The foundations call on world leaders to support the Coalition for Epidemic Preparedness Innovations (CEPI) to help end the COVID-19 crisis, prepare for future pandemics, and address epidemic threats. SEATTLE and LONDON, […]
SEATTLE–(BUSINESS WIRE)–Parse Biosciences, a company providing researchers with single-cell sequencing solutions, today announced a partnership with Research Instruments Pte Ltd to provide Parse’s Evercode Whole Transcriptome Kits (WTKs), Cell Fixation Kits and Nuclei Fixation Kits […]
Oregon is one of 41 states to pass Right to Try laws in recognition that people with terminal conditions don’t have the luxury of time to await the slow approval process for new drugs. Click […]
PORTLAND, Ore.: PORTLAND, Ore., Jan. 18, 2022 /PRNewswire/ — Allied Market Research published a report, titled, "RNA Based Therapeutic Market by Disease Type (RNA interference (RNAi) and RNA antisense), Application (Genetic Disorders and Auto Immune […]
Fox became the nonprofit’s third CEO, taking over in the weeks leading up to the Covid pandemic, which changed how the clinics treated their immunocompromised patients. Click here to view original post.
Copyright © 2022 Biotech Networks, LLC
